MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 71 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,909 | -27.5% | 15,221 | +3.7% | 0.00% | -100.0% |
Q2 2023 | $100,558 | -10.1% | 14,680 | +2.3% | 0.00% | 0.0% |
Q1 2023 | $111,825 | +4.4% | 14,355 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $107,073 | -3.5% | 14,070 | +3.4% | 0.00% | 0.0% |
Q3 2022 | $111,000 | -14.6% | 13,612 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $130,000 | -35.3% | 13,420 | -6.4% | 0.00% | 0.0% |
Q1 2022 | $201,000 | +53.4% | 14,342 | +123.7% | 0.00% | 0.0% |
Q4 2021 | $131,000 | -7.1% | 6,410 | +1.2% | 0.00% | 0.0% |
Q3 2021 | $141,000 | – | 6,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,472,331 | $11,204,439 | 7.40% |
NEA Management Company, LLC | 7,692,298 | $58,538,388 | 3.29% |
Cormorant Asset Management, LP | 2,893,717 | $22,021 | 1.47% |
Alphabet Inc. | 1,464,015 | $11,141,154 | 0.65% |
Avoro Capital Advisors LLC | 4,325,000 | $32,913,250 | 0.49% |
Casdin Capital, LLC | 510,882 | $3,887,812 | 0.30% |
RTW INVESTMENTS, LP | 1,214,572 | $9,242,893 | 0.19% |
Virtus Investment Advisers, Inc. | 12,638 | $96,175 | 0.06% |
Woodline Partners LP | 511,351 | $3,891,381 | 0.05% |
CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $214,541 | 0.04% |